SMARCA1 and cancer: The elucidation of the underlying regulatory networks and signaling pathways is likely to reveal novel therapeutic strategies centered on the NuRD-SWI/SNF axis and meant to target, in coordinated fashion, EMT in cancer cells and suppress inflammation and macrophage polarization in the TME.